Atrium Therapeutics
RNA
#4304
Rank
NZ$4.23 B
Marketcap
NZ$26.83
Share price
-6.47%
Change (1 day)
-52.12%
Change (1 year)

Atrium Therapeutics (RNA) Fails to deliver data

Key failure to deliver metrics for Atrium Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Atrium Therapeutics (RNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Atrium Therapeutics (RNA) - since 2020

Volume in USD (price x number of shares), data since 2020

Atrium Therapeutics (RNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026NZ$0.92 M-98.13%
2025NZ$49.36 M206.29%
2024NZ$16.11 M267.16%
2023NZ$4.38 M-91.34%
2022NZ$50.7 M162.44%
2021NZ$19.31 M-77.68%
2020NZ$86.53 M